Event-Driven Stocks

ARGOS THERAPEUTICS INC

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

Signs● 1 good● 5 warning● 2 severedetails ↓

Financials

SEC XBRL · annual
 FY17FY16FY15FY14FY13FY12
Revenue$105,259$146,429$518,329$2.0M$4.4M$7.0M
Operating income−$44.0M−$12.3M−$72.5M−$52.1M−$24.2M−$16.7M
Net income−$24.1M−$12.8M−$74.8M−$53.3M−$23.9M−$10.5M
Total assets$20.8M$97.2M$31.0M$64.4M$51.1M—
Total liabilities——————
Equity−$9.2M$6.2M−$28.2M$31.4M−$75.8M−$68.6M
EPS (diluted)——————
Shares out.41.4M25.3M19.7M19.7M235,707—

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2017
Operating margin
−41786.5%
Net margin
−22877.0%
Return on equity
260.8%
Return on assets
−115.9%
Return on capital (ROCE)
−392.0%
Liabilities / assets
—
Debt / equity
—
Book value / share
$-0.22
Revenue growth (YoY)
−28.1%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2017
Accruals / assets
54.6%high accruals
Piotroski F-Score
1/8weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
21
/ 100
Profitability 20Growth 0Catalyst 33Earnings quality 0Financial strength 50

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 2 severe● 5 warning● 1 good
  • Negative shareholder equity
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • Negative operating cash flow
  • High accruals — earnings-quality risk
  • Strong return on equity (>15%)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)